Patent details

EP3797296 Title: HER2 HETEROGENEITY AS A BIOMARKER IN CANCER

Basic Information

Publication number:
EP3797296
PCT Application Number:
EP2019062972
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP197275977
PCT Publication Number:
WO2019224153
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HER2 HETEROGENEITY AS A BIOMARKER IN CANCER
French Title of Invention:
HÉTÉROGÉNÉITÉ DE HER2 COMME BIOMARQUEUR DANS LE CANCER
German Title of Invention:
HER2 HETEROGENITÄT ALS EIN BIOMARKER BEI KREBS
SPC Number:

Dates

Filing date:
20/05/2019
Grant date:
04/09/2024
EP Publication Date:
31/03/2021
PCT Publication Date:
28/11/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/09/2024
EP B1 Publication Date:
04/09/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/05/2025
Expiration date:
20/05/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/08/2024
 
 

Name:
GENENTECH, INC.
Address:
1 DNA Way, South San Francisco, CA 94080, United States (US)

Name:
National Cancer Center
Address:
5-1-1, Tsukiji Chuo-ku, Tokyo 104-0045, Japan (JP)

Name:
Ventana Medical Systems, Inc.
Address:
1910 E. Innovation Park Drive, Tucson, Arizona 85755, United States (US)

Inventor

1

Name:
KUWATA, Takeshi
Address:
Japan (JP)

2

Name:
MURILLO, Adrian E.
Address:
United States (US)

3

Name:
OCHIAI, Atsushi
Address:
Japan (JP)

4

Name:
NITTA, Hiro
Address:
United States (US)

5

Name:
LO, Amy A.
Address:
United States (US)

6

Name:
KAITO, Akio
Address:
Japan (JP)

7

Name:
MUNROE, Donald G.
Address:
United States (US)

Priority

Priority Number:
201862674566 P
Priority Date:
21/05/2018
Priority Country:
United States (US)

Classification

IPC classification:
G01N 33/574;

Publication

European Patent Bulletin

Issue number:
202436
Publication date:
04/09/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages